HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of CD163 regions that are required for porcine reproductive and respiratory syndrome virus (PRRSV) infection but not for binding to viral envelope glycoproteins.

Abstract
CD163, a receptor for porcine reproductive and respiratory syndrome virus (PRRSV), possesses nine scavenger receptor cysteine-rich (SRCR) and two proline-serine-threonine (PST) domains. To identify CD163 regions involved in PRRSV infection, CD163 mutants were generated. Infection experiments showed resistance to infection following deletion of the SRCR4/5 interdomain or the Exon 13 that encodes a portion of PSTII. The mutation of a pentapeptide domain in SRCR5 and SRCR7 also conferred resistance. Mutant CD163 proteins that resisted infection retained the ability to interact with GP2, GP3, GP4 and GP5 viral glycoproteins. The contribution of multiple domains to infection but not to the binding of viral glycoproteins suggests that the envelope proteins may form multiple interactions with CD163, or that receptor regions important for infection have other cellular binding partners required for PRRSV infection. Finally, we mapped the localization the anti-CD163 2A10 antibody epitope.
AuthorsAna M M Stoian, Raymond R R Rowland, Alberto Brandariz-Nuñez
JournalVirology (Virology) Vol. 574 Pg. 71-83 (09 2022) ISSN: 1096-0341 [Electronic] United States
PMID35933832 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, Differentiation, Myelomonocytic
  • Mutant Proteins
  • Receptors, Scavenger
  • Viral Envelope Proteins
Topics
  • Animals
  • Antigens, Differentiation, Myelomonocytic (genetics, metabolism)
  • Mutant Proteins
  • Porcine Reproductive and Respiratory Syndrome
  • Porcine respiratory and reproductive syndrome virus (genetics, metabolism)
  • Receptors, Scavenger
  • Swine
  • Viral Envelope Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: